GSK Investigational Site

Snellville, Georgia 30078

0 studies enrolling now · 10 studies all time

What they study most

Diabetes Mellitus, Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Phase 2b Study of GSK4532990 in Adults With NASH — Running, not enrolling
• Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus — Completed
• Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine — Completed
• Safety and Efficacy of Albiglutide in Type 2 Diabetes — Completed
• Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed
• Safety and Efficacy Study of Albiglutide in Type 2 Diabetes — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes — Completed
• Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting — Completed